MedTrace Logo

A Helping Hand Among Low-Income Patients

NCT02147522 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 348

Last updated 2017-08-02

Study results available
· View outcomes & findings →

Summary

Study Hypotheses (Ho) and Research Questions (RQ):

* Ho1. AHH will significantly improve patient depression treatment acceptance/adherence and depression symptoms vs UC at 6 and 12 months post-baseline.
* Ho2. A Helping Hand (AHH) will significantly improve and sustain patient self-care management in Self-Efficacy for Managing Chronic Disease (SEMCD) and Quality of Life vs UC at 6 and 12 months post-baseline.
* RQ1. What is the association between depression symptoms and concurrent chronic illness self-care management over time by group?
* RQ2. Will AHH reduce hospitalizations and Emergency Room visits and improve clinic appointment-keeping?
* RQ3. Will patient care satisfaction and reported barriers to self-care management vary by study group?
* RQ4. What factors are identified via qualitative assessments of patients, promotoras, Department of Health Services (DHS) medical and social work providers, and DHS clinic/organizational leadership regarding satisfaction with, sustainable uptake of, and suggested modifications of the AHH promotora delivery model?
* RQ5. What potential technology applications would enhance promotoras delivering patient-centered self-care training and resource navigation, communicating and integrating care with DHS, and disseminating AHH?

Conditions

Interventions

BEHAVIORAL

Self-care management

AHH behavioral intervention is provided by promotoras

Sponsors & Collaborators

  • University of Southern California

    lead OTHER

Principal Investigators

  • Kathleen Ell, DSW · USC Suzanne Dworak-Peck School of Social Work

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02147522 on ClinicalTrials.gov